Literature DB >> 12538078

Essential fatty acid synthesis and its regulation in mammals.

M T Nakamura1, T Y Nara.   

Abstract

The tissue content of highly unsaturated fatty acids (HUFA) such as arachidonic acid and docosahexaenoic acid is maintained in a narrow range by feedback regulation of synthesis. Delta-6 desaturase (D6D) catalyzes the first and rate-limiting step of the HUFA synthesis. Recent identification of a human case of D6D deficiency underscores the importance of this pathway. Sterol regulatory element binding protein-1c (SREBP-1c) is a key transcription factor that activates transcription of genes involved with fatty acid synthesis. We recently identified sterol regulatory element (SRE) that is required for activation of the human D6D gene by SREBP-1c. Moreover, the same SRE also mediates the suppression of the D6D gene by HUFA. The identification of SREBP-1c as a key regulator of D6D suggests that the major physiological function of SREBP-1c in liver may be the regulation of phospholipid synthesis rather than triglyceride synthesis. Peroxisome proliferators (PP) induce fatty acid oxidation enzymes and desaturases in rodent liver. However, the induction of desaturases by PP is slower than the induction of oxidation enzymes. This delayed induction may be a compensatory reaction to the increased demand of HUFA caused by increased HUFA oxidation and peroxisome proliferation in PP administration. Recent studies have demonstrated a critical role of peroxisomal beta-oxidation in DHA synthesis, and identified acyl CoA oxidase and D-bifunctional protein as the key enzymes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12538078     DOI: 10.1016/s0952-3278(02)00264-8

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  57 in total

1.  Dietary pattern regulates fatty acid desaturase 1 gene expression in Indian pregnant women to spare overall long chain polyunsaturated fatty acids levels.

Authors:  Kalpana Joshi; Maithili Gadgil; Anand Pandit; Suhas Otiv; Kumar S D Kothapalli; J Thomas Brenna
Journal:  Mol Biol Rep       Date:  2018-12-03       Impact factor: 2.316

Review 2.  Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia.

Authors:  Korapat Mayurasakorn; Jill J Williams; Vadim S Ten; Richard J Deckelbaum
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-03       Impact factor: 4.294

3.  Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation.

Authors:  Donald B Jump; Moises Torres-Gonzalez; L Karl Olson
Journal:  Biochem Pharmacol       Date:  2010-12-22       Impact factor: 5.858

4.  Topology and static response of interaction networks in molecular biology.

Authors:  Ovidiu Radulescu; Sandrine Lagarrigue; Anne Siegel; Philippe Veber; Michel Le Borgne
Journal:  J R Soc Interface       Date:  2006-02-22       Impact factor: 4.118

5.  Abnormal n-6 fatty acid metabolism in cystic fibrosis is caused by activation of AMP-activated protein kinase.

Authors:  Obi C Umunakwe; Adam C Seegmiller
Journal:  J Lipid Res       Date:  2014-05-24       Impact factor: 5.922

6.  Kinetics of eicosapentaenoic acid in brain, heart and liver of conscious rats fed a high n-3 PUFA containing diet.

Authors:  Miki Igarashi; Lisa Chang; Kaizong Ma; Stanley I Rapoport
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-09-16       Impact factor: 4.006

7.  Dietary n-6 PUFA deprivation for 15 weeks reduces arachidonic acid concentrations while increasing n-3 PUFA concentrations in organs of post-weaning male rats.

Authors:  Miki Igarashi; Fei Gao; Hyung-Wook Kim; Kaizong Ma; Jane M Bell; Stanley I Rapoport
Journal:  Biochim Biophys Acta       Date:  2008-11-27

Review 8.  Important differences exist in the dose-response relationship between diet and immune cell fatty acids in humans and rodents.

Authors:  Kevin Fritsche
Journal:  Lipids       Date:  2007-08-23       Impact factor: 1.880

9.  Low-n-6 and low-n-6 plus high-n-3 diets for use in clinical research.

Authors:  Beth A MacIntosh; Christopher E Ramsden; Keturah R Faurot; Daisy Zamora; Margaret Mangan; Joseph R Hibbeln; J Douglas Mann
Journal:  Br J Nutr       Date:  2013-01-18       Impact factor: 3.718

10.  Rat heart cannot synthesize docosahexaenoic acid from circulating alpha-linolenic acid because it lacks elongase-2.

Authors:  Miki Igarashi; Kaizong Ma; Lisa Chang; Jane M Bell; Stanley I Rapoport
Journal:  J Lipid Res       Date:  2008-05-01       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.